Posted inBiotechnology
Refreshed Novo corrals 3 new early-stage obesity drugs from Kallyope
New-look Novo is digging deeper into its metabolic roots with three new obesity programs purchased from New York biotech Kallyope.
Posted inBiotechnology
Inside the growing world of biopharma prediction markets
In this episode of “The Top Line,” we explore the growing space of biopharma prediction markets, how they work and…
Posted inMedical Technology
Medtronic earns FDA clearance for LigaSure use with its Hugo robotic system
The FDA has cleared Medtronic’s LigaSure RAS Maryland jaw vessel sealer-divider to be used in combination with the device maker’s…
Posted inMedical Technology
FDA clears Aptitude’s latest Metrix molecular dx to test for COVID
The FDA granted Aptitude its first 510(k) clearance for the next-generation Metrix COVID diagnostic that features three-times greater sensitivity with…
Posted inBiotechnology
Xenon pauses phase 3 depression trials after psychosis events
The company has voluntarily stopped enrolling new patients in the studies in response to reports of mostly mild or moderate…
Posted inBiotechnology
BMS dumps $100M Orum degrader-antibody conjugate after glimpsing phase 1 data
Bristol Myers Squibb has axed the degrader-antibody conjugate it bought from Orum Therapeutics for $100 million, walking away from the…
Posted inBiotechnology
Inflammation biotech Electra charges up with $350M from upsized IPO
Electra Therapeutics is the latest biotech to overshoot its own IPO expectations this year, with the inflammation-focused company bringing in…
Posted inGenetics
Kidney Organoids Reveal Inflammatory Drivers of Diabetic Kidney Disease
Credit: mi-viri / iStock / Getty Images Plus Diabetic kidney disease is one of the most common and serious complications…
Posted inGenetics
Molecular Devices and STEMCELL Technologies Team Up to Automate Organoid Research
Credit: Tashi-Delek/Getty Images Molecular Devices and STEMCELL Technologies said they have a developed a validated automated workflow that can be…
Posted inGenetics
High-Grade Glioma Biology Varies by Age and Sex, Revealing Potential Treatment Targets
Credit: Dragana991/Getty Images Researchers at the Icahn School of Medicine at Mount Sinai and collaborators have identified candidate treatment targets…